Health Care • Medical Specialities
$34.94 ▼ -2.22
(-5.97%)
MKT CAP: $1.14B • VOL: 470.4K
52W L $18 52W H $44
CONSENSUS RATING DISTRIBUTION (40 DESKS)
BUY: 30 HOLD: 8
SELL: 2
12M STREET TARGET RANGE
IMPLIED: +14.0%
LOW
$29
MEDIAN
$39
MEAN
$40
HIGH
$48
STREET BS CREDIBILITY SCORE 1Y BACKTESTED
68/100
EMPIRICAL HIT RATE VS SPOT
GRADES WHETHER SELL-SIDE TARGET REVISIONS LEAD OR CHASE CSTL TAPE
CSTL // FIRM-BY-FIRM ANALYST BACKTEST & BS DETECTOR (ANR <GO>)
CURRENT 90D STREET CONSENSUS
| INSTITUTION / ANALYST | ACTION | RATING | TARGET | PRIOR PT | CALL DATE | PX AT CALL | RET SINCE CALL | 1Y ACCURACY | BS GRADE |
|---|---|---|---|---|---|---|---|---|---|
| Morgan Stanley Institutional Equity Desk | REITERATE | OUTPERFORM | $42.28 | $40.18 | 2025-02-14 | $31.80 | +9.9% | 78% | A |
| Goldman Sachs Global Research Sector Coverage | TARGET REV | STRONG BUY | $44.02 | $41.23 | 2025-02-06 | $32.84 | +6.4% | 74% | A |
| J.P. Morgan Securities US Large Cap | REITERATE | BUY | $39.83 | $38.43 | 2025-01-29 | $33.54 | +4.2% | 67% | B |
| Bernstein Autonomous Forensic Coverage | INITIATE | HOLD | $35.64 | — | 2025-01-17 | $34.24 | +2.0% | 61% | B |
| Barclays Capital Americas Research | DOWNGRADE | UNDERPERFORM | $30.75 | $33.19 | 2025-01-09 | $31.10 | -11.2% | 42% | D |
| UBS Investment Bank Institutional Desk | UPGRADE | BUY | $41.58 | $36.34 | 2024-12-18 | $30.40 | +14.9% | 72% | A |
| Citigroup Global Markets Sector Lead | TARGET REV | HOLD | $33.89 | $35.29 | 2024-12-04 | $32.49 | -4.3% | 48% | C |